CD99 and breast carcinoma: We determined the expression of CD99 by the cell lines MCF7 and MDA-MB-231, which differ in their invasive potential; MCF7 is a non-invasive ER+ breast cancer cell line, whereas MDA-MB-231 is a highly invasive triple negative breast cancer cell line (Neve et al., 2006).